505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
AAS - Acute Abdominal SeriesAASRP - American Association of Small Ruminant Practitioners
AATB - American Association of Tissue Banks
AAVLD - American Association of Veterinary Laboratory Diagnosticians
AB - Analysis Branch
ABC - American Blood Commission
ABC - America's Blood Centers
View all in FDA